JJs Janssen

J & J’s Covid-19 Vaccine Candidate

eAwaz Medicine

London – Johnson & Johnson is deploying the full strength of its science, scale and expertise to help fight the pandemic as Covid-19 continues to affect people and communities across the world. J&J’s Janssen is using the same technology that it has used in the development of its Ebola vaccine and investigational HIV, RSV and Zika vaccine candidates, which involves using an inactivated common cold virus that’s not replicating.